Catheters
Total Trials
6
As Lead Sponsor
4
As Collaborator
2
Total Enrollment
1,235
NCT02237157
A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic Cancer
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 31, 2015
Completion: Sep 30, 2016
NCT02591082
Intra-Arterial Treatment of Pancreatic Cancer Using the RenovoCath™ RC120 Catheter
Phase: N/A
Start: Dec 31, 2015
Completion: Feb 26, 2021
NCT03257033
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
Phase: Phase 3
Start: Mar 12, 2018
Completion: Sep 30, 2026
NCT06805461
PanTheR Registry Trial
Start: Aug 1, 2025
Completion: Sep 3, 2029
Loading map...